Female Pattern Baldness

(Androgen related alopecia)

Androgenic Alopecia

The cause of hereditary hair thinning and hairloss. Androgenetic Alopecia is a multi-factorial condition in which follicular exposure to androgens (testosterone, androsteinedione,and dihydrotestosterone (DHT) causes progressive follicle miniaturisation together with reduced anagen (hair growing) phase. Vellus hairs are created and remain.

Female pattern baldness caused by follicular miniaturisation associated with endocrine changes and increased androgen presence.

Other factors:

Polycystic ovarian syndrome, virilisation (& hirsutism), irregular menstrual cycle, infertility, acne & seborrhoea oleosa. Hair loss is more severe.

Androgenic Alopecia in women warrants endocrinological investigation.

Menopausal Alopecia (androgenic alopecia) is associated with hormone changes.

As estrogen reduces, hair-follicles become vulnerable to the effects of androgen exposure.

Anti-androgen therapy may reduce further hair loss.

The following drugs may limit hair loss.
Spironolactone (Aldactone, Spiroctan, Diatensec),
Cyproterone acetate (Androcur)
Diane or Flutamide (Eulexin),
Minoxidil (Regaine).
Finasteride
Propecia is not currently indicated in women however 5-alpha-reductase inhibitors are currently being considered.

Surgical & non surgical hair replacement techniques can be effective in females (and males) who suffer from pattern baldness.

For further information on female pattern baldness please contact our helpline (top left of page) and one of our on call trichologists will be happy to assist you.